• OPEN AN ACCOUNT
Indian Indices
Sensex
78,581.00 152.05
( 0.19%)
Global Indices
Nasdaq
54,113.09 913.68
(1.72%)
Dow Jones
7,758.57 137.07
(1.80%)
Hang Seng
66,265.57 2,308.04
(3.61%)
Nikkei 225
10,894.52 15.14
(0.14%)
Forex
USD-INR
95.29 -0.10
(-0.11%)
EUR-INR
109.78 -0.22
(-0.20%)
GBP-INR
128.18 -0.43
(-0.33%)
JPY-INR
0.61 0.00
(0.31%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
391.1437121
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
37.88
91987.36
EPS(TTM)
Face Value()
Div & Yield %
41.81
1
0.25
 

As on: Aug 05, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,613.40 29.60 46593 37.88
Stock Price Details
Open Price() 1,600.30
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,623.00
Today's Low () 1,567.40
52-Week High () 1636
152-Week Low () 1017
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.25
Eps 41.81
Book Value 391.1437121
Market Cap (.Cr) 91,987.36
Face Value 1
Market Lot 1
AGM Date Aug
Book Closure Date Aug
ISIN No. INE406A01037


News
Aurobindo Pharma schedules AGM
Aurobindo Pharma to conduct board meeting
Aurobindo Pharma's CuraTeQ Biologics receives ANVISA nod for Hyderabad biosimilars facility
Aurobindo Pharma announces incorporation of subsidiary in Indonesia
Aurobindo Pharma completes transfer of its branded generic products biz to Auropharm
Aurobindo Pharma USA Inc. completes acquisition of Lannett
Aurobindo Pharma's API unit clears USFDA inspection with two observations
USFDA inspects Auroactive Pharma's manufacturing unit in Andhra Pradesh
Aurobindo Pharma's API unit clears USFDA inspection with two observations
Aurobindo Pharma USA receives US FTC approval for acquisition of Lannett
More
Corporate Details
Incoporation Year   : 1986
Chairman : M R Kumar
Bussiness Group : Indian Private
Registered Office
Aurobindo Pharma Ltd
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Telangana-500038
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-40-23736370
Fax:91-40-23747340
Fax:91-22-66317458
E-Mail : cs@aurobindo.com; investorgrievances@aurobindo.com
URL : http://www.aurobindo.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • Nifty Midcap50
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi